Skip to content

Belite Bio, Inc

BLTE

CIK 0001889109

← back to feed
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
−$77.61M
−114.7% YoY FY Dec 2025
EPS Diluted (TTM)
−$2.31
−95.8% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
−$37.06M
FY Dec 2025
Cash
$352.93M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
39.34M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings